LJAC
TEVA icon

L.J. Altfest & Co’s Teva Pharmaceuticals TEVA Stock Holding History

L.J. Altfest & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-30,588
Closed -$1.76M – 121
2014
Q4 		$1.76M Buy
30,588
+234
+0.8% +$13K 1.44% 21
2014
Q3 		$1.67M Buy
30,354
+3
+0% +$159 1.64% 22
2014
Q2 		$1.65M Sell
30,351
-107
-0.4% -$5.47K 1.62% 22
2014
Q1 		$1.53M Sell
30,458
-208
-0.7% -$9.61K 1.42% 20
2013
Q4 		$1.23M Buy
+30,666
New +$1.21M 1.05% 39

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

L.J. Altfest & Co's TEVA Position: Q1 2015 in Review

L.J. Altfest & Co sold out of Teva Pharmaceuticals (TEVA) in Q1 2015, closing a stake of 30,588 shares — an estimated $1.76M sold.

L.J. Altfest & Co first reported a position in TEVA in Q4 2013 and held it in 5 quarters. The position peaked at $1.76M in Q4 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

  • L.J. Altfest & Co reported no remaining Teva Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • L.J. Altfest & Co sold 30,588 Teva Pharmaceuticals shares in Q1 2015, an estimated $1.76M.
  • L.J. Altfest & Co first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • L.J. Altfest & Co's Teva Pharmaceuticals position peaked at $1.76M in Q4 2014.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on L.J. Altfest & Co's 13F filing for Q1 2015, filed 20 Apr 2015.